Generic Name: tromethamine
Applies to tromethamine: parenteral injection
Side effects include:
Adverse effects may include respiratory depression, local irritation, tissue inflammation, injection site infection, febrile response, chemical phlebitis, venospasm, hypervolemia, IV thrombosis, extravasation (with possible necrosis and sloughing of tissues), transient decreases in blood glucose concentrations, hypoglycemia, and hepatocellular necrosis with infusion via low-lying umbilical venous catheters.  (See Warnings under Cautions.)
Applies to tromethamine: compounding powder, intravenous solution
Frequency not reported: Chemical phlebitis, venospasms[Ref]
Frequency not reported: Extravasation tissue damage and sloughing[Ref]
Frequency not reported: Transient depression of blood glucose[Ref]
Frequency not reported: Hepatocellular necrosis[Ref]
Frequency not reported: Infection at site of injection, venous thrombosis or phlebitis from site of injection extravasation[Ref]
Frequency not reported: Hypervolemia[Ref]
Frequency not reported: Febrile response[Ref]
Frequency not reported: Ventilatory depression, respiratory depression[Ref]
1. "Product Information. Tham (tromethamine)." Abbott Pharmaceutical, Abbott Park, IL. 
It is possible that some side effects of Tham may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.
